Registry of Lobbyists

Monthly Communication Report

Return to 12-Month Lobbying Summary - Miziwe Biik Development Corporation

378125-605640

Registrant name: Alexandra Spence
Client: Apotex Inc.
Associated registration: 956302-378125-1
Communication date: 2024-05-31
Posted date: 2024-05-31

Designated Public Office Holders who participated in the communication: Daniel MacDonald, Director General, Drugs for Rare Diseases
Health Canada (HC)

Michelle Boudreau, Associate Assistant Deputy Minister
Health Canada (HC)
 
Subject Matter of the communication: Economic Development,  Health
 

Return to 12-Month Lobbying Summary - Miziwe Biik Development Corporation
Date Modified: